NASDAQ:CGTX - Nasdaq - US19243B1026 - Common Stock
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 58.43M | 50.72M | 43.55M | 28.60M | 17.41M | |||
Research and Development | 45.12M | 37.20M | 30.32M | 18.57M | 12.89M | |||
Selling, General, and Administrative Expenses | 13.31M | 13.53M | 13.23M | 10.03M | 4.52M | |||
Operating Income | -58.43M | -50.72M | -43.55M | -28.60M | -17.41M | |||
Interest Income/Expense | -224.00K | -27.00K | -30.00K | 1.32M | -1.82M | |||
Other Income/Expense | 24.39M | 24.96M | 22.18M | 15.12M | 11.52M | |||
Non Recurring Items | N/A | N/A | 0.00 | 440.00K | -130.00K | |||
Income Before Taxes | -34.27M | -25.79M | -21.40M | -11.72M | -7.84M | |||
Net Income | -34.27M | -25.79M | -21.40M | -16.25M | -12.07M | |||
EBITDA | -58.33M | -50.63M | -43.47M | -28.51M | -17.31M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.96 | -0.86 | -0.91 | -0.72 | -0.58 | |||
Non GAAP EPS | -0.97 | -0.86 | -0.91 | N/A | N/A | |||
Statistics |
All data in USD